DRUG DISINVESTMENT FRAMEWORKS: COMPONENTS, CHALLENGES, AND SOLUTIONS.

Maloney, Mary Alison; Schwartz, Lisa; O'Reilly, Daria; Levine, Mitchel

Maloney, Mary Alison; Schwartz, Lisa; O'Reilly, Daria; Levine, Mitchel.

Afiliação

Maloney MA; Department of Health Research Methods, Evidence, and Impact (formerly "Clinical Epidemiology and Biostatistics),McMaster UniversityBayer HealthCare LLCalison_maloney@optimum.net.
Schwartz L; Department of Health Research Methods, Evidence, and Impact (formerly "Clinical Epidemiology and Biostatistics")Centre for Health Economics and Policy Analysis,McMaster University.
O'Reilly D; Department of Health Research Methods, Evidence, and Impact (formerly "Clinical Epidemiology and Biostatistics"),McMaster University Programs for Assessment of Technology in Health (PATH) Research Institute,St. Joseph's Healthcare Hamilton.
Levine M; Department of Health Research Methods, Evidence, and Impact (formerly "Clinical Epidemiology and Biostatistics"),McMaster University Programs for Assessment of Technology in Health (PATH) Research Institute,St. Joseph's Healthcare Hamilton.

Int J Technol Assess Health Care ; 33(2): 261-269, 2017 Jan.

Article em En | MEDLINE | ID: mdl-28703087

Assuntos

Tomada de Decisões; Indústria Farmacêutica; Avaliação da Tecnologia Biomédica; Descoberta de Drogas; Humanos

Palavras-chave

Budgets; Disinvestment; Reassessment; Technology assessment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Health_technology_assessment / Prognostic_studies / Qualitative_research / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google